This article reports an 8-year-old boy with both acute lymphoblastic leukemia and Gilles de la Tourette syndrome. Initially, for his leukemia, he was treated with chemotherapy, which resulted in severe nausea and vomiting for which he was given ondansetron. This not only relieved the target symptoms, but also those of his Gilles de la Tourette syndrome. Following a reduction of the ondansetron dosage, his Gilles de la Tourette syndrome symptoms reemerged.
American Psychiatric Association (APA).Diagnostic and statistical manual of mental disorders. DSM-IV-TR. 4th ed text revised. Washington, DC: American Psychiatric Association; 2001.
2.
World Health Organisation (WHO).International Statistical Classification of Disease and Related Health Problems: ICD 10 . Geneva: World Health Organisation ; 2007.
3.
Robertson MMInvited review. Tourette syndrome, associated conditions and the complexities of treatment. Brain. 2000; 123:425-462.
4.
Budman CL, Bruun RD, Park KS, Olson MERage attacks in children and adolescents with Tourette's disorder: a pilot study. J Clin Psychiatry.1998;59:576-580.
5.
Budman CL, Rockmore L., Stokes J., Sossin M.Clinical phenomenology of episodic rage in children with Tourette syndrome . J Psychosom Res.2003;55:59-65.
6.
Scahill L., Erenberg G., Berlin CMJr, et al. Contemporary assessment and pharmacotherapy of Tourette syndrome . NeuroRx. 2006;3:192-206.
7.
Baber N., Palmer JL, Frazer NM, Pritchard JFClinical pharmacology of ondansetron in postoperative nausea and vomiting . Eur J Anaesthesiol Suppl. 1992;6:11-18.
8.
Alhashimi D. , Alhashimi H., Fedorowicz Z.Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database Syst Rev.2006;18.
9.
Carlisle JB, Stevenson CADrugs for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev.2006;19:3.
10.
Blaine EMAcute sever depression following peri-operative ondansetron. S Afr Med J.1997;87:1013-1014.
11.
Oren DADysphoria after treatment with ondansetron. Am J Psychiatry.1995;152:1101.
12.
Robertson MM , Eapen V.The National Hospital Interview Schedule for the assessment of Gilles de la Tourette syndrome. Int J Methods Psychiatr Res. 1996; 6:203-206.
Leckman JF, Riddle MA, Hardin MT, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry . 1989; 28: 566-573.
15.
Scahill L., Riddle MA, McSwiggin-Hardin M., et al. Children's Yale-Brown obsessive compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry.1997;36:844-852.
16.
Rubini V., Padovani F.Weschler Intelligence Scale for Children-Revised (WISC-R). Italian ed. Firenze: Organizzazioni Speciali ; 1986.
17.
Kovacs M.Children's Depression Inventory (CDI). Italian ed. Firenze : Organizzazioni Speciali; 1988.
18.
Conners K.Conner's Parents and Teacher Rating Scales. San Antonio, TX: The Psychological Corporation; 1978.
19.
Achenbach T.Manual for the Child Behavior Checklist 4-18 . Burlington, VT: University Associate on Psychiatry; 1991.
20.
Toren P., Laor N., Cohen A., et al. Ondansetron treatment in patients with Tourette's syndrome. Int Clin Psychopharmacol.1999;14:373-376.
21.
Toren P., Weizman A., Ratner S., et al. Ondansetron treatment in Tourette's disorder: a 3-week, randomised, double-blind, placebo-controlled study. J Clin Psychiatry.2005;66:499-503.
22.
Sener EB, Kocamanoglu S., Ustun E., Tur A.Anesthetic management for caesarean delivery in a woman with Gilles de la Tourette's syndrome. Int J Obstet Anesth. 2006;15:163-165.
23.
Hewlett WA, Schmid SP, Salomon RMPilot trial of ondansetron in the treatment of 8 patients with obsessive-compulsive disorder. J Clin Psychiatry.2003;64:1025-1030.
24.
Johnson BA, Ait-Daoud N., Ma JZ, Wang Y.Ondansetron reduced mood disturbances among biologically predisposed, alcohol-dependent individuals. Alcohol Clin Exp Res. 2003; 27:1773-1779.
25.
Sirota P., Mosheva T., Shabtay H., et al. Use of selective serotonin 3 antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia. Am J Psychiatry.2000;157:287-289.
26.
Naidu PS, Kulkarni SKReversal of neuroleptic orofacial dyskinesia by 5-HT3 receptor antagonists . Eur J Pharmacol.2001; 420:113-117.
27.
Zullino DF, Eap CB, Voirol P.Ondansetron for tardive dyskinesia. Am J Psychiatry.2001;158:657-658.
28.
Niesler B., Frank B., Hebebrand J., Rappold G.Serotonin receptor genes HRT3A and HRT3B are not involved in Gilles de la Tourette syndrome. Psychiatr Genet.2005;15:303-304.
